FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)

FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL) is a phase 3, randomised interventional study registered as NCT02572141 by Sun Yat-sen University, with a registry enrolment figure of 738 participants, started 2015-01-01 and due to reach its primary completion in 2023-03-15. Interventions recorded: Perioperative chemotherapy with mFOLFOX6 or CAPOX regimens; Postoperative chemotherapy with mFOLFOX6 or CAPOX regimens. Conditions listed: Colon Cancer. Primary outcome: Disease-free survival. Colorectal eligibility wording from the registry: "Histological or cytological documentation of adenocarcinoma of the colon (≥ 15 cm from the anal verge)". Sites: China. No results are recorded here; the registry entry is the source.